Inflammatory Bowel Disease on the Rise Globally in the Elderly
By Lori Solomon HealthDay Reporter
WEDNESDAY, Dec. 4, 2024 -- Inflammatory bowel disease (IBD) in older adults has become a global public health burden, according to a study published in the Jan. 31, 2025, issue of Autoimmunity Reviews.
Liji Chen, from the Second Clinical Medical College of Guangzhou University of Traditional Chinese Medicine in China, and colleagues assessed the global burden of IBD in the elderly. The analysis included data from the Global Burden of Disease Study.
The researchers found that during the study period (1990 to 2019), the number of IBD prevalent cases, incident cases, disability-adjusted life-years (DALYs), and deaths in older adults increased significantly. There was a trend downward for age-standardized rates of incidence, prevalence, DALYs, and mortality. Consistently high disease burdens were seen in the Americas, European regions, and high Sociodemographic Index (SDI) countries. The fastest growth in prevalence and incidence and the fastest decline in DALYs and mortality were seen in middle SDI countries. For prevalence, incidence, and DALYs for IBD, the age-standardized rates were highest in the 60- to 64-year-old age group, while age-standardized rates of mortality were highest in the 80- to 84-year-old and 85- to 89-year-old age groups. There were no gender differences observed.
"Consequently, public health officials need to recognize the influence of aging populations and other determinants on the burden of IBD among older individuals, crafting tailored interventions to mitigate this burden effectively," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
BRCA Mutations Linked to Breast Implant Anaplastic Large Cell Lymphoma
WEDNESDAY, June 25, 2025 -- For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large...
ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 Diabetes
WEDNESDAY, June 25, 2025 -- The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 weeks in adults with early...
Paternal Mental Distress Linked to Poorer Offspring Development
WEDNESDAY, June 25, 2025 -- Paternal mental distress is associated with poorer child development, according to a study published online June 16 in JAMA Pediatrics. Genevieve Le...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.